Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis-C Virus (HCV)
...eatment. HCV infection is considered cured when a svr
of undetectable viral load is maintained more than...ered at the outset of SOC therapy provided a 77.8% svr
in HCV-infected patients. In patients who previou...sly failed SOC, DFPP treatment provided an average svr
of 71.4% versus the 51% previously referenced in T...
AGA Institute presents cutting-edge research during DDW
...rrence. I. Lowy et al. (2:30 p.m.)*
Effectiveness of the Third Eye Retroscope for Detecting Polyps in the Right Colon. J.D. Waye et al. (2:45 p.m.)
Results of PROVE3, a Phase 2b Clinical Trial Assessing Safety and Efficacy of Telaprevir in Hepatitis C Genotype-1-Infected Patients with Prior Non-re...
New treatment option for patients with chronic hepatitis C
...o have failed to respond to treatment with peg-IFN and RBV can be successfully retreated with daily CIFN and RBV," the authors conclude. "The greatest svr
rate during retreatment in the present study was observed in F0-F3 patients who had a partial virologic response during their prior course of treatmen...
2-day results predict ultimate response to therapy in chronic hepatitis C
...African Americans have consistently lower rates of svr
to interferon-based therapy, compared to Caucasian...c measurement was a reliable predictor of ultimate svr
rates. After 28 days of treatment, 22 percent of ..., "[this study] demonstrates that the low rates of svr
in African American patients in response to IFN-ba...
Study Showing Improved Virologic Response with Nitazoxanide in Chronic Hepatitis C Published in Gastroenterology
...defined as undetectable serum HCV RNA at week 4 of combination therapy, and svr
were significantly higher in patients given the triple therapy compared wit...zoxanide plus peginterferon alfa-2a had intermediate rates of RVR (54%) and svr
(61%). Adverse events were similar across treatment groups except for a hig...
Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
...a 48-week boceprevir regimen achieved a 75 percent svr
rate in patients who received 4 weeks of PEGINTRON... This represents a near doubling of the 38 percent svr
rate for patients in the control group receiving 4...) In a 28-week boceprevir P/R lead-in regimen, the svr
rate was 56 percent (n=103). Importantly, for pati...
PEGASYS(R) Proven Effective as Hepatitis C Treatment for Latino Patients, According to Article in The New England Journal of Medicine
...rated that there were differences in predictors of svr
between the two patient populations.(1) The result...eatment strategies in order to improve the rate of svr
among Latino patients infected with HCV genotype 1...4 percent (90/269) of the Latino patients achieved svr
when treated with PEGASYS plus COPEGUS.(1) In comp...
Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C
...to 48 weeks of treatment, 55 percent achieved SVR. As with adult patients, svr
in pediatric patients with HCV genotype 2 or 3 LVL was much higher than in those with genotype 1; the svr
rate was 96 percent in children with HCV genotype 2 or 3 LVL.
How to increase the chances of remaining virus free Pakistani patients with HCV?
...t virus clearance until six months after completing the treatment. This is called Sustained Virological Response (SVR). It is difficult to predict the svr
in patients receiving ongoing therapy.
A team of doctors, led by Dr. Bader Faiyaz Zuberi at Dow University of Health Sciences, Pakistan, conducted...
Treating patients with psychiatric disorders for hepatitis C
...ychotic symptoms and demonstrates that neither diagnosis adversely affected svr
or outcome. Instead, the study adds to the growing body of evidence that sh...efer et. als study means that the conclusion that there is no difference in svr
between controls and patients with mental health diagnosis is stronger than...
SVR in Medical Technology
Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients
48-week investigational regimen yielded nearly double SVR
rate compared to standard of care
Update on next-generation HCV protease inhibitor SCH 900518 presented at EASL annual meeting
COPENHAGEN, Denmark, April 23 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) toda...
Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C
FDA Approves Label Revisions Recommending New Weight-Based Dosing Regimen
KENILWORTH, N.J., March 27 /PRNewswire/ -- Schering-Plough Corporation
(NYSE: SGP ) today reported that the U.S. Food and Drug Administration (FDA)
has approved label revisions for PEGINTRON(TM) (peginterferon alfa-2b) a...
Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting
... treatment duration or a reduced PEGINTRON dose on svr
and relapse rates among treatment-naive G2/3 patie...non-inferiority between arms A and B and A and C. svr
rates overall were (A) 66.5 percent (153/230), (B)... (EASL); April 22-26, Copenhagen, Denmark.
is defined as achievement of undetectable HCV-RNA ...
Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen
... The companies also plan to explore the innovative DAA combination therapy in "treatment-experienced" patients with HCV, or those who did not achieve svr
with a previous interferon-based treatment.
Other Clinical Studies with R7227 and R7128
In addition to clinical studies of combination DAA...
Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C
...ine stratification factors, showed a difference in svr
rates of -1.8% (95% CI -8.1%, 4.5%, p=0.0008 for n...CHIEVE 2/3 : 79.8% (249/312) of patients achieved svr
in the 900-mcg albinterferon alfa-2b treatment gro...ine stratification factors, showed a difference in svr
rates of -4.8% (95% CI -10.7%, 1.1%, p=0.0086 for ...
FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
...week 12, those infected with HCV genotype 1 had an svr
rate of 48 percent (245/507), with a range of resp...A undetectable at treatment week 12 had an overall svr
of 70 percent (196/281), with a range of responses...NA at week 12 or 24 are highly unlikely to achieve svr
and discontinuation of therapy should be considere...
Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
...iority to peginterferon alfa-2a, with 48.2% (213/442) of patients achieving svr
in the 900-mcg albinterferon alfa-2b treatment group, vs. 51.0% (225/441) i...ich is adjusted for baseline stratification factors, showed a difference in svr
rates of -1.8% (95% CI -8.1%, 4.5%, p=0.0008 for non-inferiority).
Pharmasset Reports Fiscal Year End 2008 Financial Results
...nt with clevudine or tenofovir
with a combination of the two. In this study patients will be treated for two
years, followed by a determination of the svr
Pharmasset is currently enrolling two registration trials worldwide
(studies 305 and 306) and as a result of unforeseen regulatory dela...
Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
... This represents a near doubling of the 38 percent svr
24 rate for patients in the control group receivin... In a 28-week boceprevir P/R lead-in regimen, the svr
24 rate was 56 percent. Importantly, for patients...) in plasma after 4 weeks of boceprevir treatment, svr
was 94 percent in the 48 week regimen and 82 perce...
Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients
... rates with 28 weeks
of therapy and nearly doubled svr
with 48 weeks of therapy compared to
In a 48-week boceprevir regimen, the svr
rate was 74 percent at 12
weeks after the end of t...P/R lead-in). In a
28-week boceprevir regimen, the svr
rate was 56 percent at 24 weeks after
the end of t...
SVR in Medical Products
SVR Surgical Ventricular Restoration System
Description:... The svr
System eliminates the guesswork of Ventricular Res...zing ventricular size, shape and orientation
System is a comprehensive surgical therapy for pat...ricle to its optimal elliptical shape by using the svr
System and Mannequin results in significantly impr...
SVR in Biological Technology
SVR in Biological Dictionary
...es. ... Code Database. Codes for all games. svr
2009 Section. Everything svr
2009. Code -X.ws Blog ... Code -X.ws forums. svr
2009 Codes . View our huge SvR09 code index! .....